Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Clinical Investigation|December 5, 2024
Risk of cardiovascular disease in elderly subjects with obesity and liver fibrosis and the potential benefit of statin treatmentWilly B Theel, Vivian D de Jong, Manuel Castro Cabezas, et al.
Annals of Hepatology|December 5, 2025
Genetic risk factors for MASLD/MASH and cardiovascular disease in elderly individualsWilly B Theel, Vivian D de Jong, Diederick E Grobbee, et al.
European Journal of Preventive Cardiology|February 16, 2026
Effect of bempedoic acid on cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver diseaseVivian D de Jong, Steven E Nissen, William J Sasiela, et al.
Plos One|November 15, 2022
Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazarEsmée J Grobbee, Vivian D de Jong, Ilse C Schrieks, et al.
Journal of Clinical Medicine|December 11, 2025
Liver Fibrosis as a Predictor of Cardiovascular Risk in Patients with Severe ObesityAlina N Saidi, Willy B Theel, Vivian D de Jong, et al.
United European Gastroenterology Journal|August 11, 2023
A global survey of health care workers' awareness of non-alcoholic fatty liver disease: The AwareNASH surveyStan Driessen, Vivian D de Jong, Koen C van Son, et al.
Diabetes, Obesity & Metabolism|September 2, 2025
Assessing the effects of naltrexone-bupropion on hepatic steatosis and fibrosis in patients with T2DM and overweight or obesity: Insights from a placebo-controlled trialAlina N Saidi, Laura A M Konings, Carmen A W Dietvorst, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 19, 2026
Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-The-Art ReviewKirsi M A van Eekhout, Leonard D Broekman, Vivian D de Jong, et al.
BMJ Open|May 30, 2025
Global research initiative for patient screening on MASH (GRIPonMASH) protocol: rationale and design of a prospective multicentre studyVivian D de Jong, Marco Alings, Radan Bruha, et al.
Pageof 1